Cagrilintide is a long-acting analog of amylin , a hormone secreted by the pancreas alongside insulin
Patients and clinicians are encouraged to: Report any new neurological or haematological symptoms promptly to a GP, and seek urgent assessment if neurological symptoms are present Discuss nutritional supplementation as part of the initial treatment consultation Refer to a dietitian where dietary intake is significantly restricted or where multiple deficiencies are identified Report suspected adverse drug reactions including any nutritional concerns potentially related to retatrutide via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk) Stay informed as MHRA and NICE guidance evolves following any future licensing decision for retatrutide Proactive nutritional monitoring is a cornerstone of safe, responsible prescribing for any medicine that substantially alters dietary behaviour, and retatrutide should be no exception
2011;34(Suppl 2):S279-S284
Semaglutide & Tirzepatide FAQs: GLP-1 Weight Loss in St
The timeline for semaglutide appetite suppression varies, but most people notice changes within the first few days
Uncoupling agents act as lipophilic weak acids, associating with protons on the exterior of mitochondria, passing through the membrane with the bound proton, and dissociating the proton on the interior of the mitochondrion